AR089857A1 - Comprimido antiacido para refrescar el aliento - Google Patents
Comprimido antiacido para refrescar el alientoInfo
- Publication number
- AR089857A1 AR089857A1 ARP130100289A ARP130100289A AR089857A1 AR 089857 A1 AR089857 A1 AR 089857A1 AR P130100289 A ARP130100289 A AR P130100289A AR P130100289 A ARP130100289 A AR P130100289A AR 089857 A1 AR089857 A1 AR 089857A1
- Authority
- AR
- Argentina
- Prior art keywords
- tocopherol
- tablet
- breath
- anticide
- cool
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
- 239000003826 tablet Substances 0.000 abstract 4
- 229960001295 tocopherol Drugs 0.000 abstract 4
- 229930003799 tocopherol Natural products 0.000 abstract 4
- 235000010384 tocopherol Nutrition 0.000 abstract 4
- 239000011732 tocopherol Substances 0.000 abstract 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 3
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 239000011436 cob Substances 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 208000024798 heartburn Diseases 0.000 abstract 1
- 239000007935 oral tablet Substances 0.000 abstract 1
- 229940096978 oral tablet Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 125000002640 tocopherol group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261594055P | 2012-02-02 | 2012-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR089857A1 true AR089857A1 (es) | 2014-09-24 |
Family
ID=48905820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130100289A AR089857A1 (es) | 2012-02-02 | 2013-01-30 | Comprimido antiacido para refrescar el aliento |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140037759A1 (enExample) |
| EP (1) | EP2809331A4 (enExample) |
| CN (1) | CN104136033A (enExample) |
| AR (1) | AR089857A1 (enExample) |
| BR (1) | BR112014019155A8 (enExample) |
| CA (1) | CA2863389A1 (enExample) |
| CO (1) | CO7020922A2 (enExample) |
| HK (1) | HK1201179A1 (enExample) |
| IN (1) | IN2014DN06198A (enExample) |
| MX (1) | MX2014009391A (enExample) |
| WO (1) | WO2013116477A1 (enExample) |
| ZA (1) | ZA201405354B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025222289A1 (en) * | 2024-04-23 | 2025-10-30 | Biovantek | Calcium carbonate formulations and method of treatment of gastroesophageal reflux disease (gerd) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243567A (en) * | 1991-07-22 | 1995-04-27 | Bristol Myers Squibb Co | Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition |
| GB9825033D0 (en) * | 1998-11-13 | 1999-01-13 | Nycomed Pharma As | Process |
| US6358526B1 (en) * | 2000-08-16 | 2002-03-19 | Rexall Sundown | Method of making tablets and tablet compositions produced therefrom |
| WO2004064719A2 (en) * | 2003-01-24 | 2004-08-05 | State Of Israel, Ministry Of Agriculture | Synergistic compositions and methods for potentiating anti-oxidative activity |
| WO2004073632A2 (en) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories Inc. | Rapid absorption selective 5-ht agonist formulations |
| UA95093C2 (uk) * | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
| AR061093A1 (es) * | 2006-05-12 | 2008-08-06 | Drug Tech Corp | Composiciones de calcio |
-
2013
- 2013-01-30 AR ARP130100289A patent/AR089857A1/es unknown
- 2013-01-31 US US13/755,229 patent/US20140037759A1/en not_active Abandoned
- 2013-01-31 BR BR112014019155A patent/BR112014019155A8/pt not_active IP Right Cessation
- 2013-01-31 MX MX2014009391A patent/MX2014009391A/es unknown
- 2013-01-31 CA CA2863389A patent/CA2863389A1/en not_active Abandoned
- 2013-01-31 EP EP13743888.3A patent/EP2809331A4/en not_active Ceased
- 2013-01-31 IN IN6198DEN2014 patent/IN2014DN06198A/en unknown
- 2013-01-31 WO PCT/US2013/024078 patent/WO2013116477A1/en not_active Ceased
- 2013-01-31 CN CN201380010222.5A patent/CN104136033A/zh active Pending
- 2013-01-31 HK HK15101650.2A patent/HK1201179A1/xx unknown
-
2014
- 2014-07-21 ZA ZA2014/05354A patent/ZA201405354B/en unknown
- 2014-07-31 CO CO14167105A patent/CO7020922A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104136033A (zh) | 2014-11-05 |
| EP2809331A4 (en) | 2015-07-15 |
| WO2013116477A1 (en) | 2013-08-08 |
| CO7020922A2 (es) | 2014-08-11 |
| ZA201405354B (en) | 2015-11-25 |
| BR112014019155A8 (pt) | 2017-07-11 |
| HK1201179A1 (en) | 2015-08-28 |
| MX2014009391A (es) | 2014-08-27 |
| BR112014019155A2 (enExample) | 2017-06-20 |
| EP2809331A1 (en) | 2014-12-10 |
| IN2014DN06198A (enExample) | 2015-10-23 |
| US20140037759A1 (en) | 2014-02-06 |
| CA2863389A1 (en) | 2013-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20150174A (es) | Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio | |
| EA201291410A1 (ru) | Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат | |
| UA97489C2 (ru) | Фармацевтическая композиция, которая содержит аморфный розувастатин кальция | |
| BR112017001192A2 (pt) | composições de açúcar para preparação de tabletes por meio de compressão direta | |
| BR112012024673A2 (pt) | composição anestésica termogelificante | |
| BR112015011430A2 (pt) | composição para liberação imediata e prolongada | |
| AR091351A1 (es) | Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion | |
| CL2016001094A1 (es) | Silicato de zirconio microporoso para el tratamiento de hipercalemia. | |
| BR112014014795A2 (pt) | sistema de pélete de multiunidade de liberação imediata | |
| AR081165A1 (es) | Composicion dental | |
| PH12015500611A1 (en) | Oral care composition | |
| CO6150126A2 (es) | Formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina | |
| BR112017001000A2 (pt) | composições de açúcar para preparação de comprimidos por compressão direta | |
| BR112013005440A2 (pt) | "mistura de álcool de açúcar solidificada". | |
| EA201100288A1 (ru) | Таблетки телмисартана | |
| AR089857A1 (es) | Comprimido antiacido para refrescar el aliento | |
| CL2016002656A1 (es) | Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor. | |
| RU2016127361A (ru) | Гастроретентивные фармацевтические композиции для перорального введения | |
| MX2015015681A (es) | Composicion farmaceutica que comprende fingolimod. | |
| AR090169A1 (es) | Aplicacion del modafinilo | |
| MX356601B (es) | Combinación farmacéutica con efecto antimigrañoso, en presentación sólida de liberación diferenciada. | |
| AR110957A1 (es) | Agente terapéutico oral para tiroides | |
| CR20190352A (es) | Agente terapéutico oral tiroidal | |
| MX350277B (es) | Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso. | |
| EA201900368A1 (ru) | Оральное лекарственное средство для щитовидной железы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |